Navigation Links
Neurocrine Announces 12-Week Safety Results From Initial Phase IIB Study Of VMAT2 Inhibitor NBI-98854
Date:1/9/2014

61% of the subjects taking NBI-98854 were "much improved" or "very much improved" at Week 12.  The twelve-week treatment period was followed by a four-week washout period.  At the end of this washout period, only 29% of these same subjects were evaluated by the treating physicians as "much improved" or "very much improved" utilizing the CGI-TD.

"This twelve-week safety and related efficacy data is another important component for our End of Phase II FDA meeting that we plan to request during the first half of 2014," said Kevin C. Gorman, Chief Executive Officer of Neurocrine Biosciences.

Subject Profile

The Kinect study randomized 109 subjects; 81 subjects completed Week 12, of which 42  subjects were originally randomized to placebo and 39 were originally randomized to NBI-98854.  Similar to the Company's other studies, the average age of the trial participants was 55 years with an average age at onset of tardive dyskinesia of 47 years.  Approximately two-thirds of the subjects were male.

Kinect Study Design

The Kinect study was a randomized, parallel, double-blind, placebo-controlled, Phase IIb clinical trial utilizing the capsule formulation of NBI-98854 in moderate to severe tardive dyskinesia patients with underlying schizophrenia or schizoaffective disorder.  The study assessed two doses of once-daily NBI-98854 over a six-week placebo-controlled dosing period.  Half of the randomized subjects received placebo and half received one of two doses of NBI-98854.  The two NBI-98854 dosing groups consisted of a 50mg group for six weeks and a group that began at 100mg for the initial two weeks then converted to 50mg for the final four weeks of the placebo-controlled dosing period.  Subsequent to the placebo-controlled dosing, all subjects were eligible to enter a six-week open-label safety extension of 50mg of NBI-98854 administered once daily with additional A
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
2. Neurocrine Biosciences Reports First Quarter 2012 Results
3. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
4. Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2012 Financial Results
5. Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
6. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2012 Financial Results
7. Neurocrine Biosciences To Present At Lazard Capitalmarkets 9th Annual Healthcare Conference
8. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
9. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
10. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
11. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 In response to ... Association of Sierra Leone , Direct Relief ... for the treatment of local health workers who ... a new dedicated Ebola care center was constructed for foreign ... facility is not available for local Sierra Leonean health workers. ...
(Date:12/24/2014)... , Dec. 23, 2014  Medical Science Liaisons ... the key link between the medical device industry and ... more in the coming years as the device industry ... According to research by benchmarking firm, Best Practices, ... gain an important edge is by harnessing new technology ...
(Date:12/22/2014)... LAWRENCE, Mass. , Dec. 22, 2014 /PRNewswire/ ... a leading manufacturer of innovative dialysis products, announced ... (FDA) has cleared its System One™ to perform ... sleeping, known as home nocturnal hemodialysis. NxStage,s® System ... cleared by the FDA for this indication. ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2Role of Medical Science Liaisons Evolving in Medical Device Sector 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... Inc., a,biopharmaceutical company engaged in the discovery and ... diseases, announced today,that Genentech, a collaborator, has moved ... antibody, into a phase 1 clinical trial,that has ... the,safety and tolerability of both single and multiple ...
... Therapeutics, Inc. today,announced completion of a Phase ... kappa opioid agonist, CR845, under development for ... drug candidate was safe and,well-tolerated after intravenous ... expected to be associated with clinical analgesic ...
Cached Medicine Technology:Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 2Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial 3Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845 2
(Date:12/24/2014)... 25, 2014 Recently, iFitDress.com, a famous dress ... prom dresses under $150 . All these items are brand ... website has already been updated with the new range of ... ordered so far. All iFitDress.com’s designs are made according to ... using great materials. Every outfit from the company is handpicked ...
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... Today, Yunx.co.uk, a hot style dress supplier that ... occasion outfits, unveils 65 new bridesmaid dresses ... prices, up to 80% off. , Yunx.co.uk’s dresses are ... designs, gorgeous looks and delicate craftsmanship. These new bridesmaid ... to designing and offering high-quality women’s dresses with fast ...
(Date:12/24/2014)... BambooIndustry.com a famous bamboo flooring company offering bamboo ... announces its multiple layer bamboo panel board collection ... products. , Bamboo panel is the product made from ... panel board features high quality selective bamboo and eco-friendly ... bamboo panel consists of multiple layers of bamboo. , ...
(Date:12/24/2014)... Hepatitis C infection does not contribute to mental decline in ... advances have made it possible for people with HIV to ... mood swings and other types of mental impairment as they ... infections with other viruses -- a common problem in people ... prime suspects has been the hepatitis C virus, which infects ...
Breaking Medicine News(10 mins):Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2
... encephalitis in Uttar Pradesh crossed 800 Saturday. But the administration ... be at the root of the virtual epidemic. ,The ... animal is known to be the biggest host for the ... ,Uttar Pradesh officials do not even have any official ...
... Mammography is used for early detection of breast cancer and ... year and self examination of the breasts for lumps every ... of cancer is necessary to start an early treatment which ... reported in the New England Journal of Medicine has shown ...
... Louis University reported in the journal Pediatrics that pediatricians ... of obese children and help them identify the problem ... weight of children back to normal. ,Researchers feel ... during well-child visits and use that time to talk ...
... the recent advancements in the field of cancer and our ... cancer, an effective strategy to treat the disease is not ... additions to a large family known as the metalloproteinases – ... been linked with tumor metastasis, or spread, through the body. ...
... children risk heartbreak, warn doctors., ,Specialists led by Susan ... St Thomas' Hospital here, // warned that age-related fertility problems ... last 20 years, pregnancies in women over 35 have risen ... reports the online edition of BBC., ,Writing in the ...
... known that eating green vegetables, beans, nuts, cereals and fruits ... bran contains an enzyme inhibitor Inositol // pentakisphosphate which is ... enzyme Phosphoinositide 3 kinase., ,Dr. Marco Falasca and colleagues ... their study in Cancer Research Journal in which they had ...
Cached Medicine News:Health News:Pigs Population A Major Threat To Encephalitis Ravaged UP 2Health News:Digital Mammogram For Detection Of Breast Cancer In Women With Dense Breasts 2Health News:Breast Cancer Advance 2Health News:Green Beans for Cancer Prevention and Treatment. 2
Instera pins are sterile packaged and are available in 0.89, 1.1, 1.5, and 2.0mm diameters....
Knowles Pins are available in 9" (228mm) overall length with 9/64" (3.5mm) shaft diameter and 1/4" (6.4mm) square bead....
Kirschner Wires are available in four point styles ranging from .028 to .062 in. Smooth tip wire available in 4, 6 and 9 in. lengths. Threaded tip available. Material: DePuy certified stainless steel...
... INTER FIX and INTER FIX ... designed to maximize both the ... implant. Both the INTER FIX ... Fusion devices combine the features ...
Medicine Products: